Buy cheap Acomplia (Rimonabant) drugs at one of reputable online pharmacies. No prescription is needed!
Having the patent for this drug, Sanofi originally thought of and developed Acomplia to help people stop smoking, Its generic name is Rimonabant.
When Sanofi-Aventis first sought for the approval of Acomplia, the FDA turned them down. It was, however, later approved by FDA as a drug to treat weight problems. Currently approved to be marketed in Europe, this drug may yet take another year before it gets the approval of the Ministry of Health in the United States of America. The reason being the ministry wants more information on this drug.
Acomplia was allowed to be marketed in June 2006 by the authorities. It was first started in the United Kingdom and slowly started in Denmark, Ireland, Norway Finland, and Germany in the second half of 2006.
During its research stage, Acomplia was realized to lessen cardio metabolic risks and influencing sustainable weight loss. More than half of the volunteers who participated in this study have shown much improvement in their HDL cholesterol level which is beyond the anticipated increase resultant from weight loss. Clinical studies demonstrated that patients lose at least 10% of their body weight.
A few adverse effects have been noticed. More common among these are nausea and vomiting tendencies.
The European Medicines Agency (EMEA) prohibits severely depressed people or those on anti-depressants to take Acomplia as it increases the danger of committing suicide in this group of people. In lieu of this, EMEA has issues a warning informing physicians not to prescribe Acomplia to patients on anti-depressants as it poses dangers of psychiatric side effects, particularly depression.
This most recent warning was issued by the Committee for Medicinal Products for Human Use (CHMP) of EMEA after a year of following up the drug from the time it got approved. Sanofi-Aventis was requested to present all information regarding the psychiatric side effects of Acomplia.